PYPD PolyPid Ltd. - Ordinary Shares

NASDAQ · Pharmaceuticals
$4.70
Price · Aug 18, 2026
52W Range
$3–$6
61% of range
Analyst Rating
BUY
10 analysts
Price Target
$12
+150% upside
P/E (TTM)
—
ROE
—
Net Profit Margin
—

PYPD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$4.70
Market Cap
—
P/E (TTM)
—
EPS (TTM)
—
Revenue (TTM)
—
Div Yield
—
ROE
—
Debt/Equity
—
52W Range
$3 – $6

PYPD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income —
EPS —
Free Cash Flow —
Margins —

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
PYPD
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
PYPD
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
PYPD
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
PYPD
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
PYPD
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
PYPD
Peer Median

PYPD Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 10 analysts
  • Strong Buy 2 20.0%
  • Buy 7 70.0%
  • Hold 1 10.0%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

12-Month Price Target

4 analysts · 2026-08-19
Median target $12.50 +166.0%
Mean target $11.75 +150.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
0.02%
Period EPS Actual EPS Est Surprise
June 30, 2026 $-0.35 $-0.39 0.04%
March 31, 2026 $-0.35 $-0.44 0.09%
Dec. 31, 2025 $-0.41 $-0.34 -0.07%
Sept. 30, 2025 $-0.37 $-0.53 0.16%
June 30, 2025 $-0.78 $-0.56 -0.22%
March 31, 2025 $-0.70 $-0.81 0.11%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
PYPD — — — — — —
SLGL — — — — — —
MDWD — — — — — —

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 34 filers · $10.2M total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
15 (+12 vs prior Q) 0 (-2 vs prior Q) 5 (+2 vs prior Q) 5 (0 vs prior Q) +139K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
AIGH Capital Management LLC $2,823,347 555,777 27.61% Shares
Rosalind Advisors, Inc. $1,978,431 389,455 19.35% Shares
DAFNA Capital Management LLC $1,056,132 207,900 10.33% Shares
RENAISSANCE TECHNOLOGIES LLC $592,425 116,619 5.79% Shares
ADAR1 Capital Management, LLC $528,066 103,950 5.16% Shares
SYMMETRY PEAK MANAGEMENT LLC $512,475 100,881 5.01% Shares
J. Goldman & Co LP $503,850 99,183 4.93% Shares
Quadrature Capital Ltd $360,370 70,939 3.52% Shares
Connective Capital Management, LLC $343,408 67,600 3.36% Shares
JANE STREET GROUP, LLC $264,886 52,143 2.59% Shares
CITADEL ADVISORS LLC $214,793 42,282 2.10% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $203,337 40,027 1.99% Shares
Lumbard & Kellner, LLC $194,056 38,200 1.90% Shares
XTX Topco Ltd $178,039 35,047 1.74% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $93,472 18,400 0.91% Put option
AXQ CAPITAL, LP $86,853 17,097 0.85% Shares
B. Riley Wealth Advisors, Inc. $75,196 15,130 0.74% Shares
HighTower Advisors, LLC $55,880 11,000 0.55% Shares
GEODE CAPITAL MANAGEMENT, LLC $51,800 10,197 0.51% Shares
Steward Partners Investment Advisory, LLC $37,318 7,346 0.36% Shares
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO $20,157 3,968 0.20% Shares
UBS Group AG $17,160 3,378 0.17% Shares
BNP PARIBAS FINANCIAL MARKETS $15,260 3,004 0.15% Shares
MARSHALL WACE, LLP $11,842 2,331 0.12% Shares
OSAIC HOLDINGS, INC. $2,372 467 0.02% Shares
SIMPLEX TRADING, LLC $2,352 463 0.02% Shares
GROUP ONE TRADING LLC $1,676 330 0.02% Shares
MORGAN STANLEY $808 159 0.01% Shares
Caitong International Asset Management Co., Ltd $330 65 0.00% Shares
JPMORGAN CHASE & CO $239 48 0.00% Shares
HRT FINANCIAL LP $189 37,304 0.00% Shares
Rockefeller Capital Management L.P. $168 33 0.00% Shares
Virtu Financial LLC $96 18,851 0.00% Shares
SBI Securities Co., Ltd. $5 1 0.00% Shares

Company insiders 10 insiders · 4 officers · 7 directors

Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Dikla Czaczkes Akselbrad Chief Executive Officer July 15, 2026 A — 0 0 $0
Dalit Fellous Hazan Deputy CEO, EVP, RD, CRA May 11, 2026 A — 0 0 $0
Jonathan Missulawin Chief Financial Officer May 11, 2026 A — 0 0 $0
Ori Warshavsky Chief Operating Officer - US May 11, 2026 A — 0 0 $0
Nir Dror-Darwish Director July 15, 2026 A — 0 0 $0
Yechezkel Barenholz Director July 15, 2026 A — 0 0 $0
Joseph Benamram Director July 15, 2026 A — 0 0 $0
Brooke Story Director July 15, 2026 A — 0 0 $0
Robert Benjamin Stein Director July 15, 2026 A — 0 0 $0
Itzhak Krinsky Director July 15, 2026 A — 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only